Date Title Description PDF
27 Nov 2020 On business and financial situation The Company publishes the results of the PRISMA-3 study of the efficacy and safety of Doria® in schizophrenic patients in the journal npj Schizophrenia Download
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

Date Title Description PDF
07 Mar 2024 On corporate transactions ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives  Download
01 Mar 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 23 February and 29 February 2024 Download
27 Feb 2024 Annual Corporate Governance Report ROVI releases the 2023 Annual Corporate Governance Report Download
27 Feb 2024 Annual Report regarding remuneration of the members of the Board of Directors ROVI releases the 2023 annual report regarding remuneration of the members of the Board of Directors. Download
23 Feb 2024 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 16 February and 22 February 2024 Download

Pages

Date Title Description PDF
26 Jul 2018 Información sobre resultados ROVI releases the press release related to the 2018 first half financial results Download
02 Jul 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the second quarter of 2018 Download
22 Jun 2018 Información sobre dividendos The Company informs about the dividends payment Download
12 Jun 2018 Otros sobre negocio y situación financiera Corporate presentation update Download
29 May 2018 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI releases the information related to its General Shareholders Meeting Download

Pages